Klotho Neurosciences Stock Soars 1053% in Five Days as Anti-Aging Research Gains Traction

On June 10, 2025, Klotho Neurosciences (KLTO) experienced a significant surge in its stock price, rising by 10.44% and marking its fifth consecutive day of gains. The company's stock has seen a remarkable increase of 1053.18% over the past five days, reflecting a strong investor interest and confidence in its recent developments.

Klotho Neurosciences has been focusing its research on the secreted protein s-KL, which has shown potential as an anti-aging treatment due to its wide-ranging benefits. The company's investigations have indicated that enhancing Klotho gene expression may have significant implications for reducing age-related degeneration across multiple organs, thereby extending both lifespan and health span.

Recently, Klotho Neurosciences announced promising pre-clinical study findings. These results suggest that increasing the expression of the Klotho gene could potentially lead to groundbreaking advancements in anti-aging therapies. The positive outcomes from these studies have garnered substantial attention from investors, contributing to the stock's impressive performance.